Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug 6;3(3):24-30.
doi: 10.5527/wjn.v3.i3.24.

Kidney regeneration: Where we are and future perspectives

Affiliations
Review

Kidney regeneration: Where we are and future perspectives

Joao Paulo Zambon et al. World J Nephrol. .

Abstract

In 2012, about 16487 people received kidney transplants in the United States, whereas 95022 candidates were on the waiting list by the end of the year. Despite advances in renal transplant immunology, approximately 40% of recipients will die or lose graft within 10 years. The limitations of current therapies for renal failure have led researchers to explore the development of modalities that could improve, restore, or replace the renal function. The aim of this paper is to describe a reasonable approach for kidney regeneration and review the current literature regarding cell sources and mechanisms to develop a bioengineering kidney. Due to kidneys peculiar anatomy, extracellular matrix based scaffolds are rational starting point for their regeneration. The perfusion of detergents through the kidney vasculature is an efficient method for delivering decellularizing agents to cells and for removing of cellular material from the tissue. Many efforts have focused on the search of a reliable cell source to provide enrichment for achieving stable renal cell systems. For an efficient bioengineered kidney, these cells must be attached to the organ and then maturated into the bioractors, which simulates the human body environment. A functional bioengineered kidney is still a big challenge for scientists. In the last ten years we have got many improvements on the field of solid organ regeneration; however, we are still far away from the main target. Currently, regenerative centers worldwide have been striving to find feasible strategies to develop bioengineered kidneys. Cell-scaffold technology gives hope to end-stage renal disease patients who struggle with morbidity and mortality due to extended periods on dialysis or immunosupression. The potential of bioengineered organ is to provide a reliable source of organs, which can be refunctionalized and transplanted.

Keywords: Decellularization; Extra cellular matrix; Kidney regeneration; Regenerative medicine; Stem cells.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Vascular and collecting system casting of a kidney. Red: Arteries; Blue: Veins; Yellow: Ureter and collecting system. Permission of Wake Forest Institute for Regenerative Medicine.
Figure 2
Figure 2
Regeneration of a tissue/organ.
Figure 3
Figure 3
A decellularized pig kidney scaffold and its extra cellular matrix after decellularization. A: Decellularized pig kidney scaffold; B: Hematoxylin and eosin staining of the decellularized pig kidney scaffold shows a decellularized extracellular matrix (× 200); C: Hematoxylin and eosin staining of the decellularized pig kidney scaffold shows a decellularized extracellular matrix (× 400). Permission of Wake Forest Institute for Regenerative Medicine.
Figure 4
Figure 4
Normal kidney glomerulous visualized through scanning electron microscopy ( magnification × 250). Permission of Wake Forest Institute for Regenerative Medicine.

References

    1. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341:1725–1730. - PubMed
    1. Abecassis M, Bartlett ST, Collins AJ, Davis CL, Delmonico FL, Friedwald JJ, Hays R, Howard A, Jones E, Leichtman AB, et al. Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes QualityInitiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol. 2008;3:471–480. - PMC - PubMed
    1. Organ Procurement and Transplantation Network: United Network for Organ Sharing 2012 Annual Report: Health Resources and Services Administration. Richmond, US Department of Health and Human Services, 2012. Available from: http://www.unos.org/docs/AnnualReport2012.pdf.
    1. Katari R, Peloso A, Zambon JP, Soker S, Stratta RJ, Atala A, Orlando G. Renal bioengineering with scaffolds generated from human kidneys. Nephron Exp Nephrol. 2014;126:119. - PubMed
    1. Akerman ME, Chan WC, Laakkonen P, Bhatia SN, Ruoslahti E. Nanocrystal targeting in vivo. Proc Natl Acad Sci USA. 2002;99:12617–12621. - PMC - PubMed